Participants were asked to present at the lab between 0900 and 1100 h when testosterone levels are high 47, 48, to be measured and provide a 6 mL saliva sample (collected in sterile polypropylene vials) for hormonal assessment, and inform if they had or not passed their fertile days. Women with the highest levels of both hormones had the lowest WHRs, while women with low estradiol and high testosterone showed the highest WHRs. Participants were 187 young women from which waist, hips, weight, and height were measured. Findings in the present study are consistent with previous studies which have shown that LH increases with ageing but does not increase with increasing adiposity, suggesting that adiposity has effects on testosterone at the hypothalamus/pituitary level.13
Morning administration produces measurable GH elevation but at lower peak amplitude. Growth hormone secretion peaks during slow-wave sleep, and administering tesamorelin in the evening (typically 30–60 minutes before bed) aligns with this natural rhythm, optimizing pituitary response. Exactly what makes tesamorelin relevant for men over 40 whose primary metabolic risk isn't visible fat but the inflammatory, insulin-resistant tissue surrounding their organs. Subcutaneous abdominal fat decreased only 6.8% in the tesamorelin cohort, confirming VAT selectivity. A 26-week randomized controlled trial published in The Journal of Clinical Endocrinology & Metabolism enrolled 412 men aged 35–60 with elevated VAT (≥130 cm² measured via CT scan).
Ht was determined by a stadiometer calibrated to the nearest 0.1 cm and weight was measured on scales calibrated to 0.1 kg to calculate BMI (ratio of body weight in kg to height in m2).26 WC was measured, according to WHO guidelines, at the midpoint distance between the costal margin and iliac crest in the mid-axillary line on the dominant side.26 WHt ratio was calculated by dividing waist (cm) by height (cm). Subjects were also excluded if they had a BMI ≥35 kg m−2 because of the documented association of severe obesity with hypogonadotrophic hypogonadism.16, 17, 18 We investigated whether WC was a better predictor of testosterone than BMI in our cohort and, given increasing evidence of the value of indexing WC to height (Ht) as waist-to-height ratio (WHt ratio),19, 20, 21 we also examined the utility of WHt ratio for prediction of the testosterone level. We have examined the relationships of age, adiposity and testosterone levels in ageing men with symptoms consistent with hypoandrogenism but who were otherwise in good health. Additionally, we compared the strength of the associations between WWI, BMI, WC, and weight with total testosterone levels and the risk of TD, thereby enriching the data and expanding its clinical applicability. Firstly, this is the largest study to date and the first to investigate the relationship between WWI and both testosterone levels and the risk of TD. This may be because participants with higher BMI are more likely to engage in physical exercise and dietary control to reduce their weight, which can increase testosterone levels, thereby weakening the observed association. This study provides new ideas for future studies exploring the relationship between obesity and total testosterone level as well as TD.
The BMI was neither correlated with estradiol, testosterone, nor the estradiol × testosterone interaction in women in their fertile days. Participants in the fertile and the nonfertile phase were on average the same age, although the oldest participant pertains to the nonfertile sample. Following Aiken and West method to plot and obtain slopes of interactions in Multiple Regression, testosterone and estradiol mean-centered data were used in the Hierarchical Linear Regressions. To test the relation between estradiol and testosterone and WHR and BMI we used Hierarchical Linear Regression. We measured testosterone by quimioluminiscence (IMMULITE 1000 Siemens counter, ciudad). The study conforms to the guidelines of the Mexican Official Norm and the World Health Organization regulations for research with human beings.
For the multivariate models the regression coefficients, standard errors and standard coefficients as well as the r2 adjusted for inclusion of multiple dependent variables are shown. Multiple linear regression models were constructed to determine whether correcting WC for Ht made an independent contribution to the prediction of SHBG, cFT or TT. Eligible subjects had basic anthropometry (height, weight and WC) measured by the same research nurse, and two morning blood samples were collected between 8 and 11 a.m. Multivariate linear regression analysis was performed to assess their relationship with measures of adiposity. We conducted a cross-sectional study of non-smoking men aged ≥54 years recruited from the community and who were free of cancer or serious medical illness. Exogenous GH produces faster lean mass gains and general fat loss but with higher rates of edema, joint pain, and glucose intolerance.
TT, cFT, SHBG, WC, BMI and WHt ratio met skewness and kurtosis criteria for normal distribution. Free testosterone (cFT) was calculated as previously described.25 LH was measured by microparticle enzyme immunoassay (MEIA; inter-assay coefficient of variation 6.4% normal range 1.4–8.0 IU l−1). Men who had received testosterone therapy in the previous 12 months or had ever had a testosterone implant were not included. They were also excluded if they reported or were subsequently found to have greater than class I obesity (BMI ≥35 kg m−2). On univariate analysis WHt ratio was more strongly correlated with TT and cFT than either WC or BMI.

Gender: Female

Social links